CUTERA INC

CUTERA INC specializes in the design, development, and manufacturing of medical laser and light-based systems for dermatological and aesthetic applications. The company’s technical expertise centers on proprietary laser technologies, including fractional resurfacing, hair removal, vascular lesion treatment, and skin rejuvenation systems, all engineered to meet stringent clinical safety and efficacy standards. Their solutions are integrated into healthcare provider workflows with emphasis on precision control, user-friendly interfaces, and regulatory-compliant device performance. CUTERA differentiates itself through advanced optical engineering, thermal dynamics modeling, and closed-loop feedback systems that ensure consistent clinical outcomes across diverse patient populations. Award history is not available to infer specific agency engagements or procurement patterns. Consequently, no definitive relationships with federal, state, or local government entities can be confirmed based on the provided data. The primary NAICS code 339112 corresponds to Surgical and Medical Instrument Manufacturing, indicating CUTERA’s focus on producing Class II medical devices regulated under FDA 21 CFR Part 820. The company operates within the medical device vertical, serving clinical settings that require FDA-cleared, CE-marked, and ISO 13485-compliant equipment. Market positioning is aligned with private healthcare providers and medical spas, though government procurement activity cannot be substantiated from available records. CUTERA INC is structured as a domestic, for-profit corporation headquartered in Brisbane, California. The company holds no active government certifications such as 8(a), HUBZone, or WOSB. Its geographic presence is concentrated in California, with global distribution channels supporting commercial markets. While the firm is well-established in the commercial medical aesthetics sector, its footprint in the government contracting space cannot be confirmed due to insufficient award data.